Immunodiagnostic Systems Holdings, a firm which produces specialist dianostic testing kits, has said revenue for the year is expected to be six per cent ahead of the previous year at £53.4m (2011: £50.2m), in line with previous updates.
The company expects to have generated £6.9m in cash from operations during the year, with cash at the end of March at £6.8m. Borrowings decreased by £2.2m to £4.2m.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
"The board maintains the view that overall revenues will show similar year on year growth in the new financial year with the decline in manual vitamin D test volumes combined with more competitive pricing being offset by increased IDS-iSYS revenues as a result of new placements and an increasing number of automated tests becoming available."
The share price rose 8.71% to 337p by 14:35.
NR
-
How inheritance tax trick is helping families save ‘six-figure sums’Happy to skip a generation to save thousands on inheritance tax? A deed of variation could be the estate planning tool you need.
-
Nationwide: House prices unexpectedly dropped in AugustHouse prices fell by 0.1% in August in a surprise drop, according to Nationwide, as “affordability remains stretched”
